About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Ovarian Cancer Clinical Trials | 4,039 Studies Recruiting

Clinical TrialsOvarian Cancer

Ovarian Cancer Clinical Trials

Browse 4,039 clinical trials for ovarian cancer. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 2601-2620 of 4,039 trials

RecruitingA Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid TumorsThe purpose of this study is to assess BMS-986500 as monotherapy in advanced solid tumors and as combination therapy in CDK4/6 inhibitor pre-treated advanced breast cancer.NCT06997029·Birmingham, Alabama and 20 others CompletedAssessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2Lung cancer is the leading cause of cancer death in the United States. Currently it remains impossible to predict which smokers will get cancer.NCT00158145·Minneapolis, Minnesota

Related Searches

ovary cancertrials

Data from ClinicalTrials.govTerms

CompletedMulti-Centre Observational Study of Maintenance Niraparib in Treatment of Ovarian CanceRThis is a multi-centre, observational (non-interventional) study, designed to follow patients with advanced ovarian fallopian tube and primary peritoneal cancer, who are receiving…NCT04295577·Bath and 14 others

CompletedAlemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantRATIONALE: Alemtuzumab and glucocorticoids, such as prednisone or methylprednisolone, may be an effective treatment for acute graft-versus-host disease caused by a donor stem cell…NCT00410657·Seattle, Washington

UnknownPathway to Diagnosis of Ovarian CancerThe purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line…NCT01061619·Leuven and 29 others

RecruitingUterine Lavage to Detect Ovarian Cancer RiskThis clinical trial develops a non-surgical approach using uterine lavage samples to screen for progression to ovarian cancer in high-risk patients carrying BRCA mutations.NCT07772869·Seattle, Washington

CompletedClinical Benefit of Topoisomerase Downregulation1.1 To determine the regulation of topoisomerase I and II following alternating prolonged exposure to topotecan and etoposide (VP-16) 1.2 To determine the time to progression and…NCT00250094·Albuquerque, New Mexico

Enrolling by invitationStop Ovarian Cancer Young; Effect of the Opportunistic Salpingectomy on Age of MenopauseThe aim of this study is to evaluate the long-term safety of on the onset of menopause.NCT04757922·Eindhoven

CompletedPhase I Study of OSI-930 and Erlotinib in Cancer TumorsThis is a Phase I, dose escalation, safety study of OSI-930 and Erlotinib in cancer tumors.NCT00603356·Tampa, Florida and 1 other

CompletedHigh-Dose Thiotepa Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory Solid TumorsRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003173·New York, New York and 1 other

CompletedVaccine Therapy With Sargramostim (GM-CSF) in Treating Patients With Her-2 Positive Stage III-IV Breast Cancer or Ovarian CancerRATIONALE: Vaccines may help the body build an effective immune response to kill tumor cells.NCT00436254·Seattle, Washington

Not yet recruitingStratified Evaluation of PDS and NACT-IDS in Ovarian Cancer (FOCUS)The purpose of this study is to answer the fundamental question 'The Optimal Timing of Surgery' in advanced ovarian cancer patients with different tumor burden, and to perform…NCT04515602·Shanghai, Shanghai Municipality and 3 others

TerminatedStudy of PF-07263689 in Participants With Selected Advanced Solid TumorsThis is a first-in-human, Phase 1, open label, multicenter, multiple dose, dose escalation and expansion study intended to evaluate the safety, viral load kinetics and shedding…NCT05061537·Duarte, California and 2 others

CompletedPhenoxodiol Combined With Either Cisplatin or Paclitaxel in Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerRATIONALE: Drugs used in chemotherapy, such as cisplatin and paclitaxel, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00091377·New Haven, Connecticut and 1 other

CompletedIOTA Versus Pattern Recognition Method in Diagnosis of Ovarian MassesTo compare between the efficacy of IOTA simple rules and pattern recognition method in the differentiating between benign and malignant adnexal massesNCT02800031·Cairo

CompletedA Study of Cediranib and Olaparib at Disease Worsening in Ovarian CancerThis is a proof of concept study (a study to initially assess the benefit a new drug indication) of the combination of two investigational drugs cediranib and olaparib in patients…NCT02681237·Toronto, Ontario

CompletedVaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian CancerThis phase I trial is studying the side effects of vaccine therapy in treating patients with stage III-IV or recurrent ovarian cancer.NCT01322802·Seattle, Washington

Active not recruitingNGS-based Germline and Somatic Genetic Test in Ovarian CarcinomaFor patients with ovarian cancer and biologically related diseases, the implementation of genetic testing in the decision-making process could have an impact both on the risk…NCT06972693·Milan, Italy

CompletedIntraperitoneal Bortezomib and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal CancerThis phase I trial studies the side effects and best dose of intraperitoneal bortezomib when given together with intraperitoneal carboplatin in treating patients with ovarian…NCT01074411·Hartford, Connecticut and 13 others

Active not recruitingDiagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid TumorsThis is an open-label pilot study of a new PET/CT imaging agent MNPR-101-DFO\*-89Zr in patients with solid tumor cancers.NCT06337084·North Melbourne, Victoria

PreviousPage 131 of 202Next